Novel immunotherapies for the treatment of melanoma.

about

PD1 signal transduction pathways in T cells.Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapy.Immunotherapy in malignant melanoma: recent approaches and new perspectives

P2860

Q40062424-9DB1A07B-BCA2-49E0-8E36-4BDFF0D8A6D0 Q46096916-EF489CF5-688D-45D7-9044-83BC28D3BEB1 Q56894289-DE2F5A73-1D5A-4C1B-A4C8-56BC407AD162

P2860

Novel immunotherapies for the treatment of melanoma.

Item

http://www.wikidata.org/entity/Q38824190

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel immunotherapies for the treatment of melanoma.

@en

type

Item

label

Novel immunotherapies for the treatment of melanoma.

@en

prefLabel

Novel immunotherapies for the treatment of melanoma.

@en

P1476

Novel immunotherapies for the treatment of melanoma

@en

P2093

David Escors

http://www.w3.org/2001/XMLSchema#string

Estíbaliz Glaría

http://www.w3.org/2001/XMLSchema#string

Idoia Blanco-Luquin

http://www.w3.org/2001/XMLSchema#string

Maria Gato-Cañas

http://www.w3.org/2001/XMLSchema#string

Virginia Arteta-Sanchez

http://www.w3.org/2001/XMLSchema#string

P2860

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Lentiviral vectors in gene therapy: their current status and future potential

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Cancer regression in patients after transfer of genetically engineered lymphocytes

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy

Role of non-classical MHC class I molecules in cancer immunosuppression

Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines

P304

613-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2217/IMT-2015-0024

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Grazyna Kochan

Hugo Arasanz

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301794518

http://www.w3.org/2001/XMLSchema#string

P698

27140413

http://www.w3.org/2001/XMLSchema#string

Novel immunotherapies for the treatment of melanoma.

about

P2860

P2860

Novel immunotherapies for the treatment of melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698